Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients-Reference-Cited by-同舟云学术

Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients

Published:2018-12-17 Issue:12 Volume:13 Page:e0208998
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Skrtic Stanko^ORCID,Tyrberg Björn^ORCID,Broberg Malin,Ericsson Hans,Schnecke Volker,Kjaer Magnus,Hompesch Marcus,Andersson Eva-Marie,Ryberg Erik,Aivazidis Alexander,Wennberg Huldt Charlotte,Löfgren Lars,Morrow Linda,Parkinson Joanna,Rydén-Bergsten Tina,Watkins Elaine^ORCID,Sörhede Winzell Maria^ORCID

Funder

AstraZeneca AB (SE)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Type 2 Diabetes: The Pathologic Basis of Reversible beta-Cell Dysfunction;MG White;Diabetes Care,2016

2. Regulating the beta cell mass as a strategy for type-2 diabetes treatment;I Song;Current drug targets,2015

3. Severe asthma: future treatments;PM O'Byrne;Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology,2012

4. Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs;P Norman;Expert Opin Investig Drugs,2013

5. Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma;P Kuna;Drug design, development and therapy,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Step Automatic Radiosynthesis and Evaluation of [18F]TM-30089 as GPR44 Radiotracer;Pharmaceuticals;2023-10-17

2. Noncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes;Comprehensive Physiology;2023-06-26

3. [18F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44;Pharmaceutics;2023-02-02

4. Effects of Arachidonic Acid and Its Metabolites on Functional Beta-Cell Mass;Metabolites;2022-04-12

5. The Current State of Beta-Cell-Mass PET Imaging for Diabetes Research and Therapies;Biomedicines;2021-12-03